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Statement of findings
In the present study 55IgVH genes amplified from three different anatomical regions of a
rheumatoid arthritis (RA) patient were analyzed, adding further information on synovial B-cell
maturation and recirculation in RA. This analysis demonstrated somatically mutated IgVh
genes in all regions studied, with amino acid deletions and mixed IgVh molecules,
suggesting the existence of a novel pathway to generate (auto) antibody specificities.
Comparison of amino acid sequences of amplified genes that belong to the VH1 family (with
predominantly the same germline counterpart) exhibited strong homology, indicating an
apparently conserved mutational pattern. This suggests that the number of antigens that
activate Bcells in different locations is restricted. The most striking result was the finding of
clonally related sequences in different anatomical regions, indicating a recirculation of
activated Bcells between the different affected joints.
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CDR = complementarity determining region; FDC = follicular dendritic cells; FR = framework region; PCR = polymerase chain reaction; RA =
rheumatoid arthritis; R/S = ratio of replacement mutations to silent mutations.
Introduction: Although IgVgenes in rheumatoid Bcells have
been intensively analyzed, many questions concerning antigen
driven B-cell maturation and recirculation remain unanswered.
It would be interesting to know whether B-cell maturation in
rheumatoid tissue is different from that in secondary lymphatic
organs. Moreover, it would be interesting to know whether
there exists a restricted number of antigens that act on the
lesions of different anatomical sites of the RA patient, and
whether Bcells recirculate between the different joints.
Methods: RNA and genomic DNA were prepared from tissue
sections from three different anatomical sites, with different
histopathologies and different onsets (left and right peroneal
tendons and cubita synovial membrane), of a RA patient.
Genomic DNA was amplified by seminested polymerase chain
reaction (PCR), and the cDNA corresponding to the RNA was
amplified by PCR using primers specific for each IgVH family.
The obtained sequences were compared with their germline
counterparts on the V-Base data Bank [1].  An immunohisto-
chemical analysis of the infiltrate and the clinical data of local
disease activity were also included.
Results: In the locations with longer disease duration (right
peroneal tendon 5 months, left peroneal tendon 2 months) a
very intense inflammatory infiltrate with germinal centres
containing Ki-M4-positive follicular dendritic cells (FDC) was
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observed. In the location with shorter disease duration (right
cubita 2 weeks) a low, diffuse and nonfollicular infiltration with
marked oedema was detected. From the 55 analyzed clones
seven expressed nonfunctional rearrangements (pseudogenes)
with stop codons, and 48 were found to express functional
genes. Among the 48 clones that expressed functional genes,
there were two that had amino acid deletions on their
complementarity determining region (CDR)2 – clones K194/1
and K194/111 – similar to the ones described by Wilson et al
[2] and Goossens et al [3]. Two types of mixed molecules were
found. Mixed molecules of the first type (k194/57, k194/67 and
k194/109) are composed of rearrangements of two different
IgV genes. Mixed molecules of the second type (k194/126,
k194/119, k194/30 and k194/99) are composed of a IgV gene
rearrangement that is fragmented by insertions of small random
sequences. These insertions are different from the ones
described by Wilson et al [2] since they are not duplicates or
parts of IgV genes. The ratio of replacement mutations to silent
mutations (R/S ratio) increased with disease duration. There
was strong heterogeneity among the CDR3 segments.
Figure 1
(a) Comparison of the translated amino acid sequences of 19 VH1 segments with their closest germline counterparts. (b) Comparison of the
translated amino acid sequences of 19 VH1 segments with germline gene IGHV1-18*01. All sequences are deposited in Genbank database with
the following accession numbers: AF209875-209902; AF211924-211932; AF241154-241156 and AF241186-241199.
(a)
CDR1                      CDR2                                                  CDR3
IgHV1-2*02 VSCKASGYTFT GYYMH WVRQAPGQGLEWMG WINPNSGGTNYAQKFQG RVTMTRDTSISTAYMELSRLRSDDTAVYYCAR
k194-88 ----------- --fi- -------------- --d----d--------- -----w----------v-spa------i---- gggtyrnwfdp         wgqgtlvt
IgHV1-3*01 VSCKASGYTFT SYAMH WVRQAPGQRLEWMG WINAGNGNTKYSQKFQG RVTITRDTSASTAYMELSSLRSEDTAVYYCAR
k194-4 ----------- ----- -------------- --d----d--------- -----s-------------------------g avrqllypdh yyyyymdv wgqgttvt
IgHV1-8*01 VSCKASGYTFT SYDIN WVRQATGQGLEWMG WMNPNSGNTGYAQKFQG RVTMTRNTSISTAYMELSSLRSEDTAVYYCAR
k194-774 ----------- n---- -----a------l- ----------------- --a---d--k---------------------- mpaytgdfdp          wgqgtlvt
k194-89 ----------- ---f- ------------i- ---agn---r-s-n--- --ai--dp-an-v-l-----t----------- daegatkaldi         wgqgtlvt
k194-92 ----------- n---- -----a------l- ----------------- --a---d--t---fl--ri-g-d---l-f--- gvpsgtnny           wgqgtlvt
k194-98 ----------- ---f- ------------i- ----------------- -------------------------------- dygdyrv yyyygldv    wgqgtlvt
IgHV1-18*01VSCKASGYTFT SYGIS WVRQAPGQGLEWMG WISAYNGNTNYAQKLQG RVTMTTDTSTSTAYMELRSLRSDDTAVYYCAR
k194-6 ----------- g-f-h -------------- ----n----h--h---- ----------r----d----------i--gri praagiryqayryrrprggaryp
k194-62 ----------- n---- -------h------ ---tst-y-h---nfh- -----r----n--------------------- grresrhivvvtafdy    wgqgn
k194-76 ------s---- -f--- -------------- ---------d------- -------------------------------- drapycggdcystdy     wgqgtlvt
k194-79 -------d--i nf-f- ------------l- ---n--n---t-pn-r- -ls----p-----fl-----t-n---m----q drdsrgsgtwgrlgp     wgqgtlvt
k194-117 ----d-----s n-v-- -----h-------- -mn--h--------i-- ---k------------------g---e----- dldssswtgeryfdy     wgqgtvv
k194-118 ----------- ghflh ------------v- --npd-------h---- --------------------tpe--s--f-tr tpgdgwpfyf          wgqgtlvs
k194-119 ----------- --d-n -----t-------- ----------------- ------------------n------------- yctstscypgyyhmdv    wgqgtws
IgHV1-46*01VSCKASGYTFT SYYMH WVRQAPGQGLEWMG IINPSGGSTSYAQKFQG RVTMTRDTSTSTVYMELSSLRSEDTAVYYCAR
k194-58 ------t---m n-ci- -l-------p---- v---t----t------- -----k----n--f--vtr-t-a-----f--- tyfdvwsthrdaqdl     wgqgtlvt
k194-82 ------t---m n-ci- -l-------p---- v---t----t--hn--- -----k----n--f--vtr-t-a-----f--- tyfdvwsthrdalhl     wgqgtlvt
IgHV1-69*01VSCKASGGTFS SYTIS WVRQAPGQGLEWMG RIIPILGIANYAQKFQH RVTITADKSTSTAYMELSSLRSEDTAVYYCAR
k194-3 --------al- n-s-- -------k------ gt--f-nt----kd-kd ---fst-a-mtvv----tnva---a-i----g aqqlgpyrfyygvdv     wgqgtlvt
k194-5 -------df-r tnvfa -l-hv----f---- e-r-vfdvirv-er--- ---li--v-a-------hr-sl---s--f-tr tpggdwpfef          wgqgtpvt
k194-72 ----------- i---- -------------- g----f-t--------- ----st-e--y-v----r-------------- gsswysdyyyyygmdv    wgqgnp
k194-95 -----a-y--t ----- --------ap--v- --t-s-na-dt--r--- --s-s--e--t----s-a--t-d-----f-sk ngkagdffed          wgqgtlvt
(b)
IgHV1-18*01VSCKASGYTFT SYGIS WVRQAPGQGLEWMG WISAYNGNTNYAQKLQG RVTMTTDTSTSTAYMELRSLRSDDTAVYYCAR
k194-3 -------gals n-s-- -------k------ gtipflnta---kdfkd ---fs--a-mtvv----tnva-e-a-i----g
k194-4 ----------- --amh --------r----- --n-g--d-k-s--f-d ---i-s---a-------s----e--------g
k194-5 -------df-r tnvfa -l-hv----f---- e-rpvfdvirv-erf-- ---lia-v-a-------hr-sle--s--f--t
k194-6 ----------- g-f-h -------------- ----n----h--h---- ----------r----d----------i--gri
k194-58 ------t---m n-c-h -l-------p---- v-nptg-s-t----f-- -----k----n-vf--vtr-t-a-----f---
k194-62 ----------- n---- -------h------ ---tst-y-h---nfh- -----r----n---------------------
k194-72 -------g--s i-t-- -------------- g-ipif-ta-----f-- ---is--e--y-v---------e---------
k194-76 ------s---- -f--- -------------- ---------d------- --------------------------------
k194-77 ----------- n-d-n -----a------l- -mnpns---g----f-- --a--r---k-------s----e---------
k194-79 -------d--i nf-f- ------------l- ---n--n---t-pn-r- -ls----p-----fl-----t-n---m----q
k194-82 ------t---m n-c-h -l-------p---- v-nptg-s-t--hnf-- -----k----n-vf--vtr-t-a-----f---
k194-88 ----------- g-f-h -------------- --dpns-d------f-- -----w---i------vs-pa------i----
k194-89 ----------- --dfn -----t------i- -mn-g----r-s-nf-- --ai-r-p-an-v-l--s--t-e---------
k194-92 ----------- n-d-n -----a------l- -mnpns---g----f-- --a--r-------fl---i-g-----l-f---
k194-95 -----a----- --t-- --------ap--v- r-tpslnaadt--rf-- --sisa-e--t----s-a--t-------f-sk
k194-98 ----------- --dfn -----t------i- -mnpns---g----f-- -----rn--i-------s----e---------
k194-117 ----d-----s n-v-- -----h-------- -mn--h--------i-- ---k------------------g---e-----
k194-118 ----------- ghflh ------------v- --npd-------h---- --------------------tpe--s--f--t
k194-119 ----------- --d-n -----t-------- ----------------- ------------------n-------------http://arthritis-research.com/content/2/4/303
The amino acid sequences that belonged to the VH1-family
obtained from the three anatomical regions were primarily
compared with the amino acid sequences of their closest
germline counterparts (Fig.1a). One result from this
comparison was the heterogeneity in the CDR3 rearrangements.
Moreover, sequences k194/58 and k194/82 are clonally
related (confirmed at nucleotide level). Then, the 21 amino acid
sequences were compared with the most widely used germline
counterpart  IgHV1-18*01 (Fig.1b). All of these VH1
sequences had mainly conservative mutations in the framework
Figure 2
Analyses of the VH4 family amplificates. (a) Comparison of the five nucleotide VH4 sequences with their germline counterpart IgHV4-30-1/4-
31*02. (b) Clonal relation between sequences k194/100 and k194/101; replacement (r) and silent (s) mutations on the VH segment when
compared with the germline. (c) Clonal relation between sequence k194/23 amplified from the left peroneal tendon (lpt) and sequences k194/102
and k194/103 amplified from the cubita. Dashed arrows indicate the possibility of cyclic re-entry of the mature B cells into the hypermutation
process.
(a)
IgHV4-30-1/4-31*02 AGACCCTGTCCCTCACCTGCACTGTCTCTGGTGGCTCCATCAGCAGTGGTGGTTACTACTGGAGCTGGATCCGCCAGCACCCAGGGAAGGGCCTGGAGTG
k194-100 ----------------------------------------------------------------------------------------------------
k194-101 -----------------------------------------------------------------------------------t----------------
k194-23 ----------------------------------------------------------------------------------------------------
k194-103 ----------------------------------------------------------------------------------------------------
k194-102 ----------------------------------------------------------------------------------------------------
IgHV4-30-1/4-31*02 GATTGGGTACATCTATTACAGTGGGAGCACCTACTACAACCCGTCCCTCAAGAGTCGAGTTACCATATCAGTAGACACGTCTAAGAACCAGTTCTCCCTG
k194-100 --------------------------a-----t------------------t------------------------g-----------------------
k194-101 -------------------------------c------------------------tt---t--------------------------------------
k194-23 ----------------------------------------------------------------------------------------------------
k194-103 -------------------------------c--------------------------------------------------------------------
k194-102 -------------------------------c---------------------t----------------------------------------------
IgHV4-30-1/4-31*02 AAGCTGAGCTCTGTGACTGCCGCGGACACGGCCGTGTATTACTGTGCG
k194-100 ------------------------------------------------gggactacggtgactacgagagtacttaactgg...t...tcgaccc ctggg
k194-101 ------------------------------------------------gggactacggtgactacgagagtacttaactgg...t...tcgaccc ctggg
k194-23 ------------------------------------------------agagagggtcctattatagtagtggttaccccgaacgagattgacta ctggg
k194-103 ------------------c-----------------------------agagagccgaccgatatagcagctcgtacttgggcct...ttgacta ctggg
k194-102 ------------------c-----------------------------agagagccgaccgatatatcagctcgtacttgggcct...ttgacta ctggg
IgHV4-30-1/4-31*02
k194-100 gccaaggaaccctggtcaca
k194-101 gccaaggaaccctggtcaca
k194-23 gccaaggtaccctggtcaca
k194-103 gccaaggtaccctggtcaca
k194-102 gccaaggaaccctggtcaca
(b) (c)Introduction
Molecular analysis of synovial tissue and B-cell hybrido-
mas [5–7,13] has demonstrated that synovial Bcells,
which are a characteristic feature of RA [7,14,15], are
expanded in an antigen-dependent manner [16]. Because
germinal centres may be detected primarily in synovial
tissue of severely affected joints of RA patients [15,17],
this is very suggestive that antigens that drive local B-cell
expansion are directly involved in the pathogenesis of RA.
Although IgV genes in rheumatoid Bcells have been inten-
sively analyzed, many questions concerning the antigen
driven B-cell maturation and recirculation remain unan-
swered. It would be interesting to know whether B-cell
maturation in rheumatoid tissue is different from that in
secondary lymphatic organs. Moreover, it would be inter-
esting to know whether there exists a restricted number of
antigens that act on the lesions of different anatomical
sites of the RA patient, and whether Bcells recirculate
between the different joints.
Therefore, in the present study IgVH genes from synovial
tissue Bcells of different anatomical regions (with different
times of disease onset) from a RA patient were analyzed.
Furthermore, we included a histopathological analysis and
clinical data of local disease activity, which can give a
more complete picture of the role of Bcells in the patho-
genesis of RA.
Patient and methods
Patient, disease activity and tissue samples
Tissue samples (one from the right and another from the
left tendon of musculus peroneus longus and one from the
cubita synovial tissue) from a 48-year-old female patient
with confirmed seropositive RA [18] were obtained at syn-
ovectomy and were snap frozen. The patient was receiving
antirheumatic medication (gold, methotrexate and sul-
phasalazine). In the present investigation, the degree of
local disease activity was scored according to the method
of Fuchs et al [19] and Krenn et al [20], on the basis of
warmth, effusion and swelling. The patient was seroposi-
tive for rheumatoid factors. All tissues (approximately
50%) were fixed in formalin and embedded in paraffin
(Giemsa, haematoxylin and eosin staining) to be used for
diagnosis and scoring of the degree of inflammation. The
only material used for immunohistochemical analyses was
tissue that exhibited macroscopic signs of inflammation,
taken from at least three different regions of the resected
synovial membrane.
Immunohistochemistry
For immunohistochemical staining, 7-mm cryosections
(mounted on poly-L-lysine-coated slides) were used.
Immediately before staining, the cryosections were
treated with acetone for 10 min, air dried at room temper-
ature (10–20 min) and double immunohistochemical
staining was performed, as described by Krenn et al [7].
Briefly, the indirect immunoperoxidase technique (Ki-M4;
DAKO, Hamburg, Germany) was combined with the alka-
line phosphatase/antialkaline phosphatase technique
(CD20; DAKO). No counterstaining was performed. In all
cases, control staining was performed and single stain-
ings were compared with double stainings in order to
ensure that the pattern of immunohistochemical reaction
remained unaltered.
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region (FR) and nonconservative mutations in the CDR. Also,
there was an almost overall conservation of the mutational cold
spots and ‘structural cold spots’ [4] among the 19 VH1
segments. The replacement (11 from 19 replacements resulted
in a proline residue) in position 34 of CDR2 could be
interpreted as an antigen-selected mutational hotspot.
The comparison of the five sequences belonging to IgHV4-30-
1/4-31*02 resulted in two types of clonal relation (Fig. 2a). The
first type of clonal relation, between sequences k194/100 and
k194/101 (Fig.2b), suggests that both sequences are derived
from a single progenitor cell. The second type of clonal relation
is between sequences k194/23, k194/102 and k194/103
(Fig.2c). It suggests that an unmutated progenitor cell gave rise
to k194/23 (left peroneal tendon), from which k194/103 (right
cubita) derived and later generated k194/102 (right cubita).
Discussion: The analysis of the 55IgVH sequences
corroborates the findings of other groups that studied a single
location and RA B-cell hybridomas [5–10] and adds further
information on B-cell distribution and activation in RA. First,
amino acid deletions and mixed molecules could be interpreted
as novel pathways to generate antibody specificities, leading,
for instance, to autoreactive antibodies that could contribute to
the local and systemic tissue destruction. Second, an
apparently conserved mutational pattern among the 19 amino
acid VH1 segments suggests that in all three RA lesions of this
patient the synovial B cells are dealing with a restricted number
of antigens. Third, the existence of clonally related B cells in the
cubita and left peroneal tendon leaves no doubt that in this
patient there is a cyclic re-entry of mutated B cells in the
hypermutation process [11]. The already mutated B cells from
the early RA lesions sequentially colonize new germinal centers
in secondary lymphatic organs as proposed by Kepler et al [12].
These reactivated B-cells then invade new anatomical regions,
leading to the perpetuation of the chronic inflammation in RA.Histopathological score of inflammatory infiltration
A portion of tissue (approximately 50%) was fixed in for-
malin and paraffin-embedded (Giemsa, haematoxylin and
eosin staining) for use in diagnosis and scoring of the
degree of the inflammatory infiltration, which in the present
study was performed according to the method of Krenn et
al [7] on a semiquantitative 1–5 scale. Very low inflamma-
tory infiltration was indicated by 1 on the scale: the syn-
ovial intima is slightly enlarged (two to three cell layers
thick); the degree of lymphocytic infiltration is very low,
showing a diffuse pattern; and the subsynovial region
exhibits chronic tissue granulation with slight fibrosis. Low
inflammatory infiltration was indicated by 2 on the scale:
the synovial intima is slightly enlarged (two to three cell
layers thick), and the degree of inflammatory infiltration is
low, with a diffuse perivascular lymphocytic and plasma
cell infiltration; and the subsynovial region shows chronic
tissue granulation with moderate fibrosis. Moderate inflam-
matory infiltration was indicated by 3 on the scale: the syn-
ovial intima is moderately enlarged (three to five cell layers
thick), and the degree of lymphocytic infiltration is moder-
ate, with small follicle-like aggregates near small blood
vessels; and there is moderate cellularity of the subsyn-
ovial region, which exhibits slight fibrosis. Strong inflam-
matory infiltration was indicated by 4 on the scale: the
synovial intima is extensively enlarged (five to 10 cell
layers), and lymphocytes exhibit a dense follicle-like
pattern; and the ‘interfollicular’ area exhibits very high cel-
lularity without fibrosis. Very strong inflammatory infiltration
was indicated by 5 on the scale: the synovial intima is
extensively enlarged, and the distribution of lymphocytes
exhibits a dense follicle-like pattern with formation of ger-
minal centres; and granulomas and hemigranulomas can
be seen in the subsynovial region. In each histopathologi-
cal analysis, 10 fields were examined, and the most promi-
nent finding in a given field determined the score.
cDNA synthesis and polymerase chain reaction
amplification
Total RNA from about 50 tissue sections of 20mm was
prepared using the method of Chomczynski and Sacchi
[21]. cDNA synthesis was performed with 5 mg RNA
using Gibco BRL (Karlsruhe, Germany) M-MLV reverse
transcriptase according to the supplier’s manual. The
amplification of the VH genes was carried out in a 25ml
volume containing 1.75 mmol/l MgCl2, 0.4 pmol/l primer,
1U Taq polymerase (MBI Fermentas, St Leon-Rot,
Germany) and 200mmol/l of each dNTP. The cycle profile
for amplification consisted of DNA denaturation at 95°C
for 2 min, followed by 45 cycles of 94°C for 30 s, primer
annealing at 65°C for 30 s for VH3 and VH4 primers
(60°C for VH1, VH2 and VH5), and extension at 72°C for
80 s. Primer sequences were described previously [22],
and are located from codons 17 to 24 (according to V-
Base [1] sequence comparison). In brief, the following
primers, given in the 5¢–3¢direction, were used:
VH1 5¢ CCT CAG TGA AGT YTC CTG CAA GGC    3¢
VH2 5¢ GTC CTG CGC TGG TGA AAS CCA CAC A 3¢
VH3 5¢ GGG GTC CCT GAG ACT CTC CTG TGC AG 3¢
VH4 5¢ GAC CCT GTC CCT CAC CTG CRC TGT C  3¢
VH5 5¢ AAA AAG CCC GGG GAG TCT CTG ARG A  3¢
VH6 5¢ ACC TGT GCC ATC TCC GGG GAC AGT G  3¢
JH1-5 5¢ GGT GAC CAG GGT BCC YTG GCC CCA G  3¢
JH6 5¢ GGT GAC CGT GGT CCC TTG CCC CCA G  3¢
DNA extraction and amplification of IgVH genes by nested
polymerase chain reaction
DNA extraction and amplification of IgVH genes was per-
formed according to the method of Kim et al [16] with minor
modifications. In short, DNA was prepared by incubating
10×5mm tissue sections at 50°C for 1 h with proteinase K
(Boehringer Mannheim, Mannheim, Germany), which was
inactivated by heating at 95°C. To improve the specificity of
the PCR amplification, seminested PCR reactions were
carried out as follows. In the first step, amplification with Taq
polymerase was performed with VH 5¢ primers and external
JH region-specific 3¢ primers [16]. In the second round,
aliquots were specifically amplified for the heavy-chain
genes using the same 5¢ VH region primers, but internal JH
region primers (seminested PCR). In brief, the following
primers, given in the 5¢–3¢ direction, were used:
VH1 5¢ CCA TGG ACT GGA CCT GGA 3¢
VH2 5¢ ATG GAC ATA CTT TGT TCC AC 3¢
VH3 5¢ CCA TGG AGT TTG GGC TGA GC 3¢
VH4 5¢ ATG AAA CAC CTG TGG TTC TT 3¢
VH5 5¢ ATG GGG TCA ACC GCC ATC CT 3¢
VH6 5¢ ATG TCT GTC TCC TTC CTG AT 3¢
JHexternal 5¢ CTC ACC TGA GGA GAC GGT GAC C 3¢
JHinternal
5¢ TGA (AG)GA GAC GGT GAC C(AG)(GT) GT(GCT) CC 3¢
The final concentrations of the reagents were 0.1 mmol/l
MgCl2, 200mmol/l of each dNTP, 10 pmol/l of each primer
and 2 U Taq DNA polymerase. The cycle program con-
sisted of a denaturation step at 95°C for 5 min followed by
five cycles at 95°C for 40 s, 65°C for 40 s and 72°C for
1 min and 50 s; five cycles at 95°C for 40 s, 60°C for 40 s
and 72°C for 1 min and 50 s; and 25 cycles at 95°C for
40 s, 55°C for 40 s and 72°C for 1 min and 50 s. The
cycles were followed by a final 10-min incubation at 72°C.
Sequence analysis
Aliquots of the final PCR products were separated by elec-
trophoresis using a 2% low melting agarose gel (Roth,
Karlsruhe, Germany), and DNA bands in the range of
350 bp were purified from the agarose gel using High-Pure
DNA gel extraction kit (Boehringer Mannheim). Cloning of
PCR fragments was performed using the pCR-Script Amp
SK(+) cloning kit (Stratagene, Heidelberg, Germany).
Positive clones were sequenced using the DyeDeoxy
Termination Cycle Sequencing Kit (Applied BioSystems
http://arthritis-research.com/content/2/4/303Inc, Weiterstadt, Germany), and analyzed using an auto-
mated DNA sequencer ABIPrism373 (Applied BioSystems
Inc).  Both strands were sequenced using T3 and T7
primers. The sequences were analyzed using DNAman for
Windows software (Lynon BioSoft, Vaudreuil, Quebec,
Canada), Genebank and v-Base databases [1].
Results
Local disease activity and duration of local disease
The female patient, who suffered from a confirmed
seropositive RA with involvement of tendon sheaths,
exhibited severe signs of local disease activity, with
tenosynovitis of the right distal peroneus longus tendon
and left distal peroneus longus tendon, and synovialis of
the right cubita (Table 1). The durations of local disease
were 5 months, 2 months and 2 weeks, respectively.
Histopathology and immunohistochemistry of synovial tissue
A heterogeneous inflammatory infiltrate could be observed
in the different locations. In both locations with longer
disease duration (right peroneal tendon [5 months] and left
peroneal tendon [2 months]) a very intense inflammatory
infiltrate, with Ki-M4-positive FDC-containing germinal
centres (Fig. 3a, 3b and insert), could be observed (inflam-
matory score 5). However, in the right cubita (disease dura-
tion 2 weeks) a low, diffuse and nonfollicular infiltration with
marked oedema (inflammatory score 2) was detected
(Fig. 3c). The latter synovialitis histopathologically showed a
more acute inflammatory reaction, whereas in the right and
left peroneal tendons the morphological pattern of a typical
chronic tendosynovitis was present. Immunohistochemi-
cally, the right and left peroneal tendons exhibited a dense
follicular-like infiltration, with Ki-M4-positive FDC and periph-
erally located CD20-positive B lympocytes representing
germinal centres (insert in Fig. 3a and 3b). In the right cubita
only a very low and diffuse nonfollicular distribution of lym-
phocytes without Ki-M4-positive FDC could be recognized.
Comparison of the mutated VH segments with the
germline genes
Presence of pseudogenes
From the 55 analyzed clones (Table 2), seven expressed
nonfunctional rearrangements (pseudogenes) with stop
codons, and 48 were found to express functional genes.
The existence of pseudogenes has been largely described
in IgV genes amplified from genomic DNA of healthy
[1,23] and diseased [4,24] individuals. Furthermore, the
presence of pseudogenes in diseased individuals is
largely related to specific mutations on the RYGW motifs
[4]. Based on these findings, it is not surprising that we
found pseudogenes in the genomic DNA amplificates
(k194/81, k194/120 and k194/126). However, we also
identified pseudogenes in the cDNA amplificates
(k194/30,  k194/33,  k194/130 and  k194/135), which
have not yet been described in the literature. These
pseudogenes could be the product of a PCR artifact
(maybe due to an elevated number of cycles) that intro-
duced STOP-codons in the IgV-gene sequence. However,
because the sequences were read in both directions
(5¢–3¢ and 3¢–5¢), and both readings yielded the same
confirmatory results, we do not consider the pseudogenes
in the cDNA amplificates to be PCR artifacts. The exis-
tence of such pseudogenes could be explained by the
findings of Drapkin et al [25] that DNA repair enzymes are
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Table 1
Comparison between local disease activity and molecular data
Local disease activity SR/SS
Disease duration Inflammation Pattern Presence
Location (weeks) Swelling Tenderness score of infiltration of FDCs CDR FR
Right peroneal tendon 20 (+++) (+++) 5 Follicular (+) 7.50 1.48
Left peroneal tendon 8 (+++) (+++) 5 Follicular (+) 3.65 1.70
Right cubita 2 (+++) (+++) 2 Diffuse (–) 3.00 1.39
Figure 3
Histopathology (haematoxylin and eosin) and immunohistochemistry
(double staining: indirect immunoperoxidase and alcaline phosphatase
in insert of parts a and b) of rheumatoid synovial tissue from three
different anatomical locations of the RA patient. These are as follows:
(a) right peroneal tendon sheath; (b) left peroneal tendon sheath with
inserted figure showing Ki-M4 positive FDC network (brown)
surrounded by CD20+ B lymphocytes (blue), representing a germinal
centre; and (c) synovial membrane from the right cubita. Arrows
indicate enlarged synovial intima (original magnification 350×).
(b) (a) (c)part of the RNA polymerase II transcription initiation
process. Hence there could be a defective DNA repair
mechanism that, in the case presented here, could lead to
the introduction of STOP codons in the RNA molecule.
Deletions and mixed molecules
Among the 48 clones that express functional genes, there
were two presenting amino acid deletions on their CDR2:
clones K194/1 and K194/111. These detected deletion
events should be regarded as the result of somatic hyper-
mutation and not as a PCR artifact, because they were
found in the intrinsic somatic hypermutation hotspots
[26–29], and also involved triplets from CDR2, which
leaves the transcripts functionally in frame without pro-
foundly altering the backbone structure of the molecule, as
defined by Wilson et al [2].
Two types of mixed molecules were found. Mixed mole-
cules of the first type (k194/57, k194/67 and k194/109)
are composed of rearrangements of two different IgV
genes. These two mixed molecules could be considered
PCR artifacts, like the ones described by Bridges et al
[30] for amplified Vk gene segments in RA synovium. This
could be due to the fact that RNA is very unstable and
could have fragmented while the samples had not been
snap frozen (for reasons of hygiene it is not allowed to
take snap-freezing apparatus into the operating theatre).
However, two facts counter the PCR artifact hypothesis.
First, the B cells of the RA synovial samples are used in
our laboratory not only for IgV analysis, but also for
hybridoma production, so their RNA must be intact to
allow successful cell fusion [5,6]. Second, the sequences
were read in both directions (5¢–3¢ and 3¢–5¢), and both
readings yielded the same confirmatory results of func-
tional mixed molecules.
Mixed molecules of the second type (k194/126,
k194/119,  k194/30 and  k194/99) are composed of a
IgV gene rearrangement fragmented by insertions of small
random sequences. These insertions are different from
the ones described by Wilson et al [2] since they are not
duplicates or parts of IgV genes. On one hand, this could
happen because of the insertion of incorrectly amplified
fragments, thus resulting in a PCR hybrid artifact. On the
other hand, however, the sequences were read in both
directions (5¢–3¢ and 3¢–5¢), and both readings yielded
the same confirmatory results. Also the use of nested
PCR to amplify the genomic DNA strongly reduces the
possibility of amplification and insertion of incorrect frag-
ments [24,31], thus rendering improbable the hypothesis
of PCR artifact.
Although not considering the deletions and the mixed mol-
ecules as PCR artifacts, we made the decision not to con-
sider them for further mutational analyses, because a
rational comparison with these sequences is not possible.
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Table 2
B-cell clones from the different anatomical localisations are
shown with closest identified VH germline gene segment and
its homology
Location Clone VH family Germline Homology (%)
Left peroneal tendon
K194/1# 1 IgHV1-18*01 79.4
K194/3 1 IgHV1-69*01 73.6
K194/4 1 IgHV1-3*01 96.6
K194/5 1 IgHV1-69*01 66.9
K194/6 1 IgHV1-18*01 88.2
K194/8 2 IgHV2-70*11 98.1
K194/9 2 IgHV2-70*01 92.0
K194/23 4 IgHV4-30-1/4-31*02 100.0
K194/24 3 IgHV3-53*02 95.1
K194/25 4 IgHV4-59*01 91.0
K194/26 4 IgHV4-30-4*06 89.0
K194/27 5 IgHV5-51*01 96.1
K194/28 5 IgHV5-51*01 85.0
K194/30## 5 IgHV5-51*01 P
K194/31 5 IgHV5-51*01 93.8
K194/33 5 IgHV5-51*01 P
K194/42 5 IgHV5-51*01 98.0
K194/81 2 IgHV2-70*01 P
Cubita
K194/57## 1 IgHV1-18*01//IgHV1-46*01 ND
K194/58 1 IgHV1-46*01 66.5
K194/62 1 IgHV1-18*01 91.6
K194/67## 1 IgHV1-18*01//IgHV1-2*02 ND
K194/72 1 IgHV1-69*01 95.3
K194/76 1 IgHV1-18*01 97.9
K194/77 1 IgHV1-8*01 94.5
K194/79 1 IgHV1-18*01 75.7
K194/82 1 IgHV1-46*01 80.3
K194/88 1 IgHV1-2*02 91.2
K194/89 1 IgHV1-3*01 86.0
K194/92 1 IgHV1-8*01 88.7
K194/95 1 IgHV1-69*01 76.9
K194/98 1 IgHV1-8*01 96.2
K194/99## 2 IgHV2-70*01 92.0
K194/100 4 IgHV4-30-1/4-31*02 97.0
K194/101 4 IgHV4-30-1/4-31*02 97.0
K194/102 4 IgHV4-30-1/4-31*02 97.0
K194/103 4 IgHV4-30-1/4-31*02 98.0
K194/104 6 IgHV6-1*01 88.0
Right peroneal tendon
K194/109## 1 IgHV1-8*01//IgHV1-18*01 ND
K194/111# 1 IgHV1-18*01 77.0
K194/114 1 IgHV1-18*01 79.0
K194/117 1 IgHV1-18*01 93.0
K194/118 1 IgHV1-18*01 88.0
K194/119## 1 IgHV1-18*01 96.0
K194/120 1 IgHV1-18*01 P
K194/121 2 IgHV2-70*01 97.0
K194/122 5 IgHV5-51*01 94.0
K194/123 5 IgHV5-51*01 87.0
K194/124 5 IgHV5-51*03 92.0
K194/125 5 IgHV5-51*03 98.0
K194/126## 5 IgHV5-51*01 P
K194/127 5 IgHV5-51*01 94.0
K194/130 5 IgHV5-51*01 P
K194/135 5 IgHV5-51*01 P
K194/136 5 IgHV5-51*01 98.0
#, Clone presenting amino acid deletions; ##, mixed molecule;
P, pseudogene; ND, not determined; Bold indicates amplification
from genomic DNA.Local overall R/S ratios increase with disease duration
The 41 in-frame functional clones accumulated between 4
and 46 replacements on their amino acid sequence. The
R/S ratios in the CDR of all clones from each anatomical
region were all higher than 3. There was a direct correla-
tion between the R/S values and the time of local disease
duration. Locations with longer disease activity (right and
left peroneus longus tendons) also had higher R/S values
in the CDR than the location with a later onset (right
cubita; Fig. 4).
Heterogenity among the CDR3s
Even though a relatively reduced number of different VH
germline gene segments was used, the CDR3s were
encoded by D-gene segments that differed in both amino
acid sequence and length, and all of the six known human
JH gene segments were found. As expected for the
normal adult Ig repertoire [32], the JH4 and JH6 segments
were the most commonly used.
Comparison of the sequences from the same VH family
amplified from each location
The comparison was restricted to the VH1 and VH4 fami-
lies, because they yielded the more relevant results.
VH1 family
The mutational patterns of immunoglobulin VH1 genes
was studied by Borretzen et al [33] in peripheral blood
monoclonal IgM rheumatoid factors of healthy individuals
and RA patients. However, this kind of mutational pattern
comparison has not been extended to B cells from RA
synovial tissue. As is widely known, the primary structure
of an antibody, formed by the amino acid sequence, deter-
mines all of its chemical and biological properties. Thus,
the amino acid sequences that belong to the VH1 family
obtained from the three anatomical regions were com-
pared with the amino acid sequences of their closest
germline counterparts (Fig. 1a). One result from this com-
parison is the heterogenity in the CDR3 rearrangements.
Moreover, sequences k194/58 and k194/82 are clonally
related (confirmed at nucleotide level, data not shown).
Then, the 21 amino acid sequences were compared with
the most widely used germline counterpart IgHV1-18*01
to determine whether a common motif could be discerned
(Fig. 1b). As postulated, the conservation of the amino
acid sequence of all three FRs is crucial for the interaction
with the antigen [34]. In fact, for FR 1+2 we observed
highly conserved regions (Fig. 5).
The residues at positions number 6, 10 and 11 from FR1
and the complete FR2 (except positions 22 and 26)
showed a high conservation of the amino acid residues. In
FR3, we found high sequence diversity (Figs 1b and 5),
even though there was still conservation within residues
48–49, 51–52, 54, 56, 58–60, 62–64, 66–67, 69 and
71–75. All the other positions had a total of 30 noncon-
servative substitutions, and therefore they probably do not
play a determining role in the antigen-mediated activation
process. As expected, the number of nonconservative
substitutions in both CDR1 and CDR2 was highly ele-
vated. Nevertheless, the 3¢ end of CDR2, covering
residues 41–47, contained a total of 25 substitutions, but
only five were nonconservative (Fig. 5). More striking evi-
dence was that residues in position 34 of CDR2 in 11 out
of 19 replacements resulted in a proline residue. It could
even be speculated that position 34 of CDR2 may be an
antigen-selected mutational hotspot, because it does not
belong to the defined somatic hypermutation hotspots
[28,29]. In position 45 there are 13 substitutions from Leu
to Phe, but 12 of them cannot be considered real substitu-
tions because, as shown in Figure 1a, the germline IgHV1-
18*01 is the only one to have a Leu in that position
instead of the more frequent Phe. Therefore, in this posi-
tion we only considered Leu–Ile and one Leu–Phe (for
k194/62) as real substitutions.
As stated by Chang and Casali [35], the CDR1 is the
IgVH gene region with higher susceptibility to amino acid
replacement, and this was in fact the case for all the
obtained sequences. The CDR1 had the highest number
of nonconservative replacement mutations, which makes it
very unlikely to be primarily involved in the antigen-medi-
ated activation.
VH4 family
From the seven amplified sequences of the VH4 family (four
from the cubita and three from the left peroneal tendon) five
had IgHV4-30-1/4-31*02 as their closest germline counter-
part, and the other two had IgHV4-59*01 and IgHV4-30-
4*06 (Table 2). When comparing the five sequences that
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Figure 4
Total R/S ratios in the FR 1+2+3 and CDR 1+2 of B-cell clones from
each different anatomical region of the RA patient: (a) right peroneal
tendon sheath; (b) left peroneal tendon sheath; (c) cubita.belong to IgHV4-30-1/4-31*02 (Fig. 2a) with each other,
there was evidence of two different clonal relations. The first
clonal relation was between sequences k194/100 and
k194/101 (Fig. 2b), suggesting that both sequences are
derived from a single progenitor cell with the rearrangement
IgHV4-30-1/4-31*02_IgHD4-17*01_IgHJ5*02. The
second clonal relation was between sequences k194/23,
k194/102 and  k194/103  (Fig. 2c), suggesting that
sequence  k194/102 was derived from k194/103, which in
turn was derived from sequence k194/23 that had a prog-
enitor cell with the rearrangement IgHV4-30-1/4-
31*02_IgHD2-2*02inv_IgHJ4*01. Furthermore, the small
number of mutations of all of these five sequences when
compared with the germline could be taken as indirect evi-
dence that the germline already encodes a high-affinity anti-
body, as suggested by Williams and Taylor [8].
Discussion
Various studies have demonstrated that somatically mutated
B-cells are present in RA synovial tissue [5,6,8–10] and in
human RA hybridomas [7,36]. However, we studied the IgV
genes of synovial B cells taken from different anatomical
regions, with distinct histopathology and local disease dura-
tion, of the same RA patient. The analysis of the 55 IgVH
sequences corroborates the findings of other groups that
studied a single location, and adds further information on B-
cell distribution and activation in RA.
Amino acid deletions and mixed molecules: novel
pathways to generate antibody specificities?
Recently, the introduction of deletions and duplications, in
addition to nucleotide exchanges, has been described as
a feature of the somatic hypermutation process [2,3].
Amino acid deletions in the IgV genes have only been
described in lymphomas and healthy secondary lymphatic
tissue, however [2,3]. In the present study we report the
existence of such amino acid deletions in the IgV genes
from synovial B cells of an autoimmune disease. For the
first time, amino acid deletions in the VH genes were
found in B cells of an autoimmune disease. The detection
of these deletion events in RA synovialitis stresses the
functional homology of the synovial membrane to sec-
ondary lymphatic tissue.
Also for the first time, IgV gene mixed molecules were found
that are formed either by two segments of different IgV
genes or by a IgV gene rearrangement that is fragmented by
random insertions. The mechanisms that underlie the forma-
tion of these mixed molecules could be modified pathways
to the unified model for somatic hypermutation, as proposed
by Maizels [37] (Fig. 6); an initiating lesion could lead to a
hypermutation either templated (using another germline
gene as template) or untemplated (by inserting small
random sequences). In some cases the process of untem-
plated hypermutation could lead to the insertion of STOP
codons, rendering the gene nonfunctional.
Hence, the production of mixed molecules and the intro-
duction of deletions could represent novel pathways for
RA synovial B cells to generate new specificities that lead,
for instance, to autoreactive antibodies that could con-
tribute to the local and systemic tissue destruction.
Apparent mutational pattern among the 19 amino acid VH1
segments
The comparison of the amino acid sequences of the
19 VH1 segments from the different locations provided
some valuable data on the interaction of the RA synovial
B cells and their target antigen(s).
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Figure 5
Amino acid replacement plot, calculated across translated amino acid
sequences shown in Figure 3b. (a) Conservative replacement (Y« D,
E; « N D, E; L« V, A, F, I; S« N, T, Q; D« E; K« R);
(b) indeterminant replacement (H« all amino acids; M« all amino
acids; G« A, V, L, I, F, P; W« R, K, S, T, N, Q, D, E; P« A, V, I, L,F;
K, R« N, Q, S, T, Y; C« D, E, K, N, Q, R, S, T, Y; Y« K, R, N, Q, S,
T); and (c) nonconservative replacement (R, K« E, D; D, Y, E« A, I ,L,
P, F; S, T, Q, N« A, I, L, V, P, F; R, K« A, I, L, P,V, F; C« A, I, P, V, L,
F; W« A, I, P, F, V, L; G« C, D, E, R, K, N, Q, S, T, Y). The type of
replacement was defined on the basis of [45–48].
(a)
(b)
(c)All of the VH1 sequences had mainly conservative mutations
in the FR and nonconservative in the CDR, thus, agreeing
with the results from Wedemayer et al [38]. When resolving
at 2.1 Å, the crystal structure of a germline antibody Fab
fragment and its complex with hapten, they observed an
expansion of the binding potential of the primary antibody
repertoire. This expansion derived from configurational stabil-
ity due to antigen binding and somatic mutations, nonconser-
vative mutations in the CDR that raised the affinity for the
hapten, and conservative mutations in the FR.
Another important finding was the almost overall conserva-
tion of the mutational cold spots and ‘structural cold
spots’ [4] among the 19 VH1 segments. The interesting
absence of mutations in positions 17, 23, 28, 30, 48, 56
and 71 suggests the existence of more ‘structural cold
spots’ in the VH1 family than those described.
During the germinal center reaction (for instance in the fol-
licles of the two earlier lesions of this patient), rearranged
B cells with low-affinity receptors improve their affinity by
somatic hypermutation [39,40]. Nevertheless, these muta-
tions can also decrease the affinity instead of expanding it.
Therefore, as reported by Meffre et al [41], under appro-
priate regulation VDJ rearrangements take place in mature
B cells of human tonsil. Hence, the heterogenity observed
on the CDR3 of the 19 VH1 sequences could be due to a
reactivation of the rearrangement process in order to
rescue these RA synovial B cells from deleterious somatic
mutations, or to further increase their binding affinity.
Based on the above findings, there appears to be a con-
served mutational pattern among all 19 VH1 segments,
hence suggesting that in all three RA lesions of this
patient the synovial B cells were activated by a restricted
number of antigens. This is strengthened by the replace-
ment in position 34 of CDR2, which could be interpreted
as an antigen-selected mutational hotspot.
Cyclic re-entry of mutated rheumatoid arthritis synovial B-
cells in the hypermutation process
The increment of mutations with antigen dose [42] possibly
indicates that the maturation of the immune response is a
continuous process with the production of an increasing
number of hypermutated memory B cells with time. In the
special case of RA, the local joint destruction may release
antigens that lead to the hypermutation process. Character-
istic for B-cell hypermutation are the elevated R/S ratios in
the CDR. In the present study there was a direct associa-
tion of the overall R/S ratios with the duration of local
disease. Synovial B cells were shown to undergo a germinal
center-like reaction in RA [5,16]. Therefore, we suggest that
the activated B cells from this patient have undergone a
local maturation in the germinal center-like structures
detected in the peroneal tendons (left and right). On the
other hand, the fact that one lesion was free from FDCs and
exhibited only an acute inflammatory infiltrate could support
the model proposed by Oprea and Perelson [43]; the
already mutated germinal centre B cells from the peroneal
tendons might have migrated into the cubita synovial tissue,
as has been shown for closely located finger joints [44], and
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Figure 6
Generation of mixed molecules according to Maizels [37]. In RA synovial tissue mixed molecules could be the result of a templated or an
untemplated hypermutation DNA repair process.re-entered in a cyclic hypermutation process. The apparent
existence of a mutational pattern on amino acid level of
clones obtained from the different regions could support
this hypothesis. However, the existence of clonally related
B-cells in the cubita and left peroneal tendon leaves no
doubts that, in the patient studied, there is cyclic re-entry of
the mutated B cells from the early RA lesions in the hyper-
mutation process [11] that sequentially colonize new germi-
nal centers, as proposed by Kepler and Perelson [12].
These reactivated B cells then invade new anatomical
regions, leading to the perpetuation of the chronic inflamma-
tion in RA.
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